Objective: To review the pharmacodynamics and pharmacotherapeutic use of intravenous
artesunate for the treatment of severe malaria. Data Sources: Literature was retrieved …

Background Intravenous (IV) artesunate is the treatment of choice for severe malaria. In
Europe, however, no GMP-manufactured product is available and treatment data in …

This review summarizes progress in treating severe and complicated malaria, which are
global problems, claiming at least one million lives annually, and have been accompanied …

Background Artesunate (ART) is an artemisinin derivative used as monotherapy for the
treatment of severe malaria and in combination with a partner drug for non-severe malaria …

Background Severe malaria results in over a million deaths every year, most of them in
children aged less than five years and living in sub-Saharan Africa. Injectable artesunate …

Background Severe malaria is a medical emergency with high mortality. Prompt
achievement of therapeutic concentrations of highly effective anti-malarial drugs reduces the …

Objective Intravenous artesunate is commonly used in the emergency treatment of patients
with severe falciparum malaria in Asia. The choice of doses used has been empirical. To …

Malaria remains one of the most important infectious diseases in the world. The WHO
estimated 435,000 deaths from malaria in 2017, the large majority due to Plasmodium …

Eurosurveillance | Intravenous artesunate recommended for patients with severe malaria:
position statement from TropNetEurop 1887 Other sites: ECDC European Antibiotic …

Synopsis Artesunate is an antimalarial agent, available in oral, rectal and parenteral
formulations, that provides a rapid clinical effect in patients with Plasmodium falciparum …